Assembly Biosciences (ASMB) Competitors

vTv Therapeutics (NASDAQ:VTVT) and Assembly Biosciences (NASDAQ:ASMB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, community ranking, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

Which has more risk & volatility, VTVT or ASMB?

vTv Therapeutics has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Comparatively, Assembly Biosciences has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500.

Do institutionals and insiders hold more shares of VTVT or ASMB?

17.5% of vTv Therapeutics shares are held by institutional investors. Comparatively, 19.9% of Assembly Biosciences shares are held by institutional investors. 1.7% of vTv Therapeutics shares are held by insiders. Comparatively, 4.1% of Assembly Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Does the MarketBeat Community prefer VTVT or ASMB?

vTv Therapeutics received 110 more outperform votes than Assembly Biosciences when rated by MarketBeat users. However, 59.21% of users gave Assembly Biosciences an outperform vote while only 57.83% of users gave vTv Therapeutics an outperform vote.

Company	Underperform	Outperform
vTv Therapeutics	Outperform Votes 351 57.83%	Underperform Votes 256 42.17%
Assembly Biosciences	Outperform Votes 241 59.21%	Underperform Votes 166 40.79%

Is VTVT or ASMB more profitable?

Assembly Biosciences' return on equity of 0.00% beat vTv Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
vTv Therapeutics	N/A	N/A	-104.93%
Assembly Biosciences	N/A	-117.69%	-72.43%

Does the media refer more to VTVT or ASMB?

In the previous week, Assembly Biosciences had 19 more articles in the media than vTv Therapeutics. MarketBeat recorded 20 mentions for Assembly Biosciences and 1 mentions for vTv Therapeutics. Assembly Biosciences' average media sentiment score of 1.05 beat vTv Therapeutics' score of 0.00 indicating that vTv Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
vTv Therapeutics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Assembly Biosciences	1 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	5 Very Negative mention(s)	Neutral

Do analysts prefer VTVT or ASMB?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
vTv Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Assembly Biosciences	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has higher valuation and earnings, VTVT or ASMB?

vTv Therapeutics has higher earnings, but lower revenue than Assembly Biosciences. vTv Therapeutics is trading at a lower price-to-earnings ratio than Assembly Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
vTv Therapeutics	$2.02M	35.78	-$20.25M	-$10.07	-2.38
Assembly Biosciences	$7.16M	10.26	-$61.23M	-$17.05	-0.79

Summary

Assembly Biosciences beats vTv Therapeutics on 8 of the 14 factors compared between the two stocks.